Identifikation und immunologische Charakterisierung von MHC ...

6. Literaturverzeichnis
Altieri DC (2001). The molecular basis and potential role of survivin in cancer
diagnosis and therapy. Trends Mol. Med. 7: 542-547.
Altieri DC (2003). Blocking survivin to kill cancer cells. Methods Mol. Biol. 223:
533-542.
Altomonte, M., Fonsatti, E., Visintin, A., Maio, M. (2003). Targeted therapy of
solid malignancies via HLA class II antigens: a new biotherapeutic approach?
Oncogene 22: 6564-6569.
Ambrosini, G., Adida, C., Altieri, DC (1997). A novel anti-apoptosis gene,
survivin, expressed in cancer and lymphoma. Nat. Med. 3: 917-921.
Ambrosini, G., Adida, C., Sirugo, G., Altieri, DC (1998). Induction of apoptosis
and inhibition of cell proliferation by survivin gene targeting. J. Biol. Chem.
273: 11177-11182.
Andersen, MH, Pedersen, LO, Capeller, B., Brocker, EB, Becker, JC, Thor SP
(2001). Spontaneous cytotoxic T-cell responses against survivin-derived MHC
class I-restricted T-cell epitopes in situ as well as ex vivo in cancer patients.
Cancer Res. 61: 5964-5968.
Andersen, MH, Thor, SP (2002). Survivin-a universal tumor antigen. Histol.
Histopathol. 17: 669-675.
Anderson, MS, Venanzi, ES, Klein, L., Chen, Z., Berzins, SP, Turley, SJ, von
Boehmer, H., Bronson, R., Dierich, A., Benoist, C., Mathis,D. (2002). Projection
of an immunological self shadow within the thymus by the aire protein.
Science 298(5597): 1395-1401.
96